MedPath
HSA Approval

ONCOPROS - ABIRATERONE ACETATE TABLETS USP 250MG

SIN15933P

ONCOPROS - ABIRATERONE ACETATE TABLETS USP 250MG

ONCOPROS - ABIRATERONE ACETATE TABLETS USP 250MG

April 24, 2020

RANBAXY (MALAYSIA) SDN. BHD.

RANBAXY (MALAYSIA) SDN. BHD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantRANBAXY (MALAYSIA) SDN. BHD.
Licence HolderRANBAXY (MALAYSIA) SDN. BHD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

L02BX03

abiraterone

Manufacturer Information

RANBAXY (MALAYSIA) SDN. BHD.

Sun Pharmaceutical Industries Limited

Active Ingredients

Abiraterone Acetate

250.00mg

Abiraterone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ONCOPROS - ABIRATERONE ACETATE TABLETS USP 250MG - HSA Approval | MedPath